Cargando…
Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study
BACKGROUND: Pancreatic signet ring cell carcinoma (PSRCC) is a rare tumour subtype with poorly understood epidemiological characteristics and prognosis. We attempted to comprehensively characterise the epidemiology and survival outcomes of PSRCC. METHODS: Patients diagnosed with PSRCC between 2000 a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667582/ https://www.ncbi.nlm.nih.gov/pubmed/36384527 http://dx.doi.org/10.1186/s12876-022-02543-z |
_version_ | 1784831752678670336 |
---|---|
author | Nie, Duorui Lan, Qingxia Huang, Yue Fang, Chongkai Cao, Yang Chen, Yao |
author_facet | Nie, Duorui Lan, Qingxia Huang, Yue Fang, Chongkai Cao, Yang Chen, Yao |
author_sort | Nie, Duorui |
collection | PubMed |
description | BACKGROUND: Pancreatic signet ring cell carcinoma (PSRCC) is a rare tumour subtype with poorly understood epidemiological characteristics and prognosis. We attempted to comprehensively characterise the epidemiology and survival outcomes of PSRCC. METHODS: Patients diagnosed with PSRCC between 2000 and 2018 were identified using Surveillance, Epidemiology and End Results Stat 8.3.9.2 software. Age-adjusted incidence and survival were calculated. Survival curves were plotted using the Kaplan–Meier method, and the differences between survival curves were compared using the log-rank test. Cox proportional hazards models were used to evaluate factors that independently predict overall survival. The primary analysis was a complete case analysis; multiple imputations were employed in a sensitivity analysis. RESULTS: We identified 585 eligible patients with PSRCC. The overall annual incidence from 2000 to 2018 was 0.349 (95% CI, 0.321–0.379) per million population. The incidence increased significantly in patients over 55 years of age and peaked at about 80 years of age (2.12 per million). Males and Black patients had the highest incidence. The observed survival rates at 1, 2 and 5 years were 20.1, 8.3 and 3.4%, respectively. Survival analysis revealed that primary surgery and chemotherapy are effective treatments for patients with PSRCC (P < 0.05). According to multivariate Cox regression analysis, early stage and receiving surgery and chemotherapy were favourable factors (P < 0.05). Similar conclusions were drawn from the interpolated data. CONCLUSIONS: PSRCC is a highly malignant tumour that predominates in elderly, male and Black patients. The prognosis is poor with a 5-year survival rate of 3.4%; however, multivariate analysis and adjusted models accounting for missing data revealed that early diagnosis, surgery and chemotherapy are effective in improving the prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02543-z. |
format | Online Article Text |
id | pubmed-9667582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96675822022-11-17 Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study Nie, Duorui Lan, Qingxia Huang, Yue Fang, Chongkai Cao, Yang Chen, Yao BMC Gastroenterol Research BACKGROUND: Pancreatic signet ring cell carcinoma (PSRCC) is a rare tumour subtype with poorly understood epidemiological characteristics and prognosis. We attempted to comprehensively characterise the epidemiology and survival outcomes of PSRCC. METHODS: Patients diagnosed with PSRCC between 2000 and 2018 were identified using Surveillance, Epidemiology and End Results Stat 8.3.9.2 software. Age-adjusted incidence and survival were calculated. Survival curves were plotted using the Kaplan–Meier method, and the differences between survival curves were compared using the log-rank test. Cox proportional hazards models were used to evaluate factors that independently predict overall survival. The primary analysis was a complete case analysis; multiple imputations were employed in a sensitivity analysis. RESULTS: We identified 585 eligible patients with PSRCC. The overall annual incidence from 2000 to 2018 was 0.349 (95% CI, 0.321–0.379) per million population. The incidence increased significantly in patients over 55 years of age and peaked at about 80 years of age (2.12 per million). Males and Black patients had the highest incidence. The observed survival rates at 1, 2 and 5 years were 20.1, 8.3 and 3.4%, respectively. Survival analysis revealed that primary surgery and chemotherapy are effective treatments for patients with PSRCC (P < 0.05). According to multivariate Cox regression analysis, early stage and receiving surgery and chemotherapy were favourable factors (P < 0.05). Similar conclusions were drawn from the interpolated data. CONCLUSIONS: PSRCC is a highly malignant tumour that predominates in elderly, male and Black patients. The prognosis is poor with a 5-year survival rate of 3.4%; however, multivariate analysis and adjusted models accounting for missing data revealed that early diagnosis, surgery and chemotherapy are effective in improving the prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02543-z. BioMed Central 2022-11-16 /pmc/articles/PMC9667582/ /pubmed/36384527 http://dx.doi.org/10.1186/s12876-022-02543-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nie, Duorui Lan, Qingxia Huang, Yue Fang, Chongkai Cao, Yang Chen, Yao Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title | Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title_full | Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title_fullStr | Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title_full_unstemmed | Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title_short | Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
title_sort | epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667582/ https://www.ncbi.nlm.nih.gov/pubmed/36384527 http://dx.doi.org/10.1186/s12876-022-02543-z |
work_keys_str_mv | AT nieduorui epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy AT lanqingxia epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy AT huangyue epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy AT fangchongkai epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy AT caoyang epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy AT chenyao epidemiologyandprognosticanalysisofpatientswithpancreaticsignetringcellcarcinomaapopulationbasedstudy |